Pharmaceuticals, Biotechnology and Life Sciences
AbCellera will use its world-leading antibody drug discovery platform in a multi-year collaboration to identify antibodies against up to nine targets
AbCellera’s world-leading drug discovery technology identifies antibodies for potential use in drugs to treat and prevent COVID-19 got cash support from Canadian Government of $175.6 million.
VANCOUVER, British Columbia–(BUSINESS WIRE)–#antibodies–AbCellera Biologics Inc., a global leader in therapeutic antibody discovery from natural immune systems, today announced that…